New psoriasis pill tested for clearer skin
NCT ID NCT06723171
Summary
This study tested a daily pill called IRX4204 to see if it could safely improve skin symptoms in adults with mild to moderate plaque psoriasis. For 28 days, participants took either the drug or a placebo (inactive pill), and researchers compared their skin clearance and quality of life. The trial was a Phase 2 study but is currently suspended.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Not posted
Webster, Texas, 77598, United States
Conditions
Explore the condition pages connected to this study.